[在高凝血状态下,血栓生成试验的有用性]
Paul Billoir1, Sébastien Miranda2, Hervé Lévesque2
1Service d'Hématologie Biologique, Centre hospitalier Universitaire Charles Nicolle, 1 rue de Germont, 76031 Rouen, France.
Annales de biologie clinique
|February 26, 2025
概括
血栓生成试验 (TGA) 可以评估出血和凝血风险. 协调TGA方法可以在各种条件下改善对血栓事件的预测.
科学领域:
- 凝血科学是一门凝血科学.
- 血液静止研究 血液静止研究
- 血栓形成和出血风险评估
背景情况:
- 血栓是血液静止和凝固的核心.
- 血栓生成试验 (TGA) 评估了凝血动态.
- TGA对于评估出血和血栓形成风险非常有价值.
研究的目的:
- 系统地审查有关血栓性血栓性病的血栓学研究.
- 评估TGA在各种血栓状况中的有用性.
主要方法:
- 使用TGA进行的原始调查的系统审查.
- 2003年1月至2022年6月期间以英语出版的研究.
- 包括条件:静脉血栓栓塞,动脉疾病,怀孕,抗脂综合征,宪法性血栓,瘤学.
主要成果:
- 选择了80项研究;大多数有<100名患者.
- 两项大型研究 (>1000名患者) 将增加的血栓生成与更高的血栓复发或心血管死亡率联系起来.
- 使用TGA研究了所有血栓友好症的情况.
结论:
- 在TGA中缺乏标准化,阻碍了临床研究的发展.
- 协调TGA实践可能会提高对动脉和静脉血栓事件的预测.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
592
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
592
01:24Disorders of Hemostasis
679
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
679
01:16Clot Retraction and Fibrinolysis
3.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.8K
01:09Coagulation
4.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.2K